An Ovine Adenovirus Vector Lacks Transforming Ability in Cells That Are Transformed by AD5 E1A/B Sequences  by Xu, Z.Z. et al.
d
1
Virology 270, 162–172 (2000)
doi:10.1006/viro.2000.0236, available online at http://www.idealibrary.com onAn Ovine Adenovirus Vector Lacks Transforming Ability in Cells That Are
Transformed by AD5 E1A/B Sequences
Z. Z. Xu,* M. Nevels,† E. S. MacAvoy,* L. J. Lockett,* D. Curiel,‡ T. Dobner,† and G. W. Both*,1
*CSIRO, Molecular Science, North Ryde, New South Wales 2113, Australia; †Institut fu¨r Medizinische Mikrobiologie und Hygiene, Universita¨t
Regensburg, D-93053 Regensburg, Germany; and ‡Gene Therapy Center, University of Alabama, Birmingham, Alabama 35294
Received November 29, 1999; returned to author for revision January 3, 2000; accepted February 2, 2000
Adenoviruses of the Mastadenovirus and Aviadenovirus genera are able to transform certain cell types and induce tumor
formation in susceptible animals. For the mastadenoviruses the E1A/B sequences are largely responsible for these
properties but E4 sequences may also be involved. The transforming sequences of the aviadenoviruses, which lack E1A/B
and E4 homologues, have not yet been fully identified. The recent proposal for a third genus of adenoviruses, which
apparently lack an E1A homologue and have weak E1B homology, prompted an examination of the transforming properties
of ovine adenovirus OAV287 (OAV), the prototype member of the new group. When OAV and human adenovirus type 5 (Ad5)
were used to infect primary rat embryo cells, transformed foci developed in Ad5- but not in OAV-infected cultures. Similarly,
after plasmid transfection, baby rat kidney cells were transformed by Ad5 E1A/B but not by OAV sequences. When CSL503
cells, an ovine cell line that is permissive for OAV, were transfected with Ad5 E1A/B sequences, transformed foci again
appeared. However, plasmids or fragments containing complete or partial OAV genome sequences did not detectably
transform CSL503 cells under the same conditions. When Ad5 E1A/B sequences were incorporated into the complete OAV
genome and transfected, transformed clones were again obtained, showing that the gene dosage and transfection conditions
were not limiting for transformation. The provision of Ad5 E1A and OAV sequences in combination marginally increased the
number of morphologically altered foci in baby rat kidney cells but failed to induce multilayered focus formation. The data
suggest that OAV lacks transforming functions in the cell types examined. Additional information suggesting that OAV may
have a fundamentally distinct strategy for replication compared with other Ads is discussed. © 2000 Academic Press
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Many adenoviruses (Ads) are known to carry onco-
genes. Members of the mastadenoviruses, including hu-
man and animal Ads, as well as CELO, a member of the
aviadenoviruses, can readily transform cells in culture
(Anderson et al., 1969a,b; Darbyshire, 1966; Kinjo et al.,
1969; McAllister et al., 1969; Trentin et al., 1962). How-
ever, these viruses differ in their ability to induce tumor
formation in animals. CELO virus rapidly induces tumors
in newborn rodents (Sarma et al., 1965). Among human
Ads, the group A viruses such as Ad12 are highly onco-
genic, while the group C (including Ad5) and E viruses
are not known to be tumorigenic (reviewed in Flint, 1980;
Horwitz, 1990; Shenk, 1996).
The transforming properties of the mastadenoviruses
reside primarily in the E1A and E1B genes at the left end
of the genome. These sequences are always present
and expressed in transformed cells; transfection of these
genes is sufficient to transform cells, and mutations in
these genes abolish their transforming ability (reviewed
in Flint, 1980; Horwitz, 1990; Shenk, 1996). The Ad2/5 E1A
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162products bind to proteins of the cellular retinoblastoma
(pRb) protein family (Whyte et al., 1988), thereby releas-
ng E2F transcription factors that regulate cell cycle pro-
ression into S phase (Nevins, 1992). The E1B 55-kDa
rotein binds to the tumor suppressor protein p53 and
locks p53-mediated apoptosis (White, 1998). The E1B
9-kDa protein is also anti-apoptotic (Rao et al., 1992).
ithin the E4 region the ORF1 product of human Ad9
group D) virus has oncogenic properties (Javier et al.,
992; Thomas et al., 1999). The Ad5 E4 ORF3 and ORF6
roducts also augment transforming activity of the E1A
nd E1B genes (Moore et al., 1996; Nevels et al., 1997,
1999a,b). The identity of the oncogenic genes in CELO
virus is less clear. There are no identifiable E1A/B or E4
regions in the genome (Chiocca et al., 1996), but recently
two proteins, GAM-1 and ORF22, that interact with pRb
were identified (Lehrmann and Cotten, 1999). GAM-1
may also functionally substitute for the E1B 19-kDa pro-
tein (Chiocca et al., 1997).
Recently, based on phylogenetic analyses (Dan et al.,
1998; Harrach et al., 1997) and the distinctive genome
arrangement of newly characterized viruses (Hess et al.,
1997; Vrati et al., 1996a), the existence of a third genus,
Atadenovirus, has been proposed (Benko and Harrach,
1998). Members of this group include ovine adenovirus
OAV287 (OAV) and egg drop syndrome virus-76 (both fully
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163LACK OF TRANSFORMATION BY OVINE ADENOVIRUSsequenced) and bovine Ads type 4–8. OAV and EDS-76
lack an identifiable E1A region but at the left end of the
genome two reading frames that show a low level of
homology with the Mastadenovirus E1B proteins are
present (Hess et al., 1997; Vrati et al., 1996a). The right-
and regions of these genomes contain open reading
rames (ORFs) that show strong homology with a motif
hat is found in E4 ORF6 of mastadenoviruses (Vrati et al.,
996a). There are also additional ORFs whose function is
nknown. The ability of bovine Ad types from this group
o cause tumors in vivo has been examined. In one study
umor formation was reported in hamsters inoculated
ith Ad type 8 (Rondhuis, 1973). In the other study, none
f Ads types 4–10 induced tumor formation (Mohanty,
971). Thus, the oncogenic potential of individual mem-
ers of the atadenoviruses is unclear. However, as cur-
ent OAV vectors carry gene insertions and retain their
ull complement of viral genes, their transforming ability
s of interest from both practical and fundamental view-
oints. Our intention is to use OAV vectors to deliver
nzyme/prodrug gene therapy to cancer cells, in the first
nstance. In this regime, OAV-infected cells are killed
hen a prodrug is converted to the active form by an
nzyme that is encoded by the therapeutic gene. This
trategy provides a further safeguard against an unde-
irable outcome related to expression of viral genes.
In this work, we have investigated the ability of OAV
equences to transform primary rat cells and the sheep
FIG. 1. Infection of primary rat embryo cells with Ad5 or OAV217A. (A)
of 50 PFU/cell. The phase or fluorescence (third from left) images of th
uninfected cells. (B) Cells infected at m.o.i. 10 with OAV wild-type or Ad5
from an Ad5 focus picked at 20 days and amplified.ung cell line CSL503 in vitro. The data indicate that
either cell type is transformed by OAV sequences underonditions where Ad5 E1A/B sequences induce multilay-
red, transformed focus formation.
RESULTS
nfection and transfection of primary rat cells by Ad5
nd OAV
Primary rat embryo cells, in which Ad replication is
emipermissive, have been used as one benchmark as-
ay for transforming ability. To investigate whether OAV
ould transform such cells, 105 cells seeded at near
confluence in 24-well plates were infected at a multiplic-
ity of infection (m.o.i.) of 50 PFU/cell with OAV217A, a
recombinant that expressed the GFP protein from the
HCMV promoter. Cells were similarly infected with Ad5
as a positive control and initially observed for 4–6 days.
During this time most cells in the OAV-infected monolay-
ers produced GFP, showing that they were infected. For
both the OAV and Ad5 infections, there were only a small
number of rounded cells by day 4 (Fig. 1A) and this
limited cytopathic effect (cpe) did not significantly
progress by day 6 (data not shown). Moreover, when 5%
of day 7 supernatant from these OAV217A-infected cul-
tures was passaged on fresh primary rat embryo cells,
few green cells were seen and no cpe was observed by
day 14. Day 14 supernatant (5%) produced no detectable
fluorescence after an additional passage. Thus, OAV did
not replicate in these cells. Cells were also infected at an
ere mock-infected or infected with Ad5 or OAV217A viruses at an m.o.i.
are shown at day 4 postinfection. No fluorescence was detected for
ultured for up to 80 days. The cells in the right-hand panel were derivedCells w
e cellsm.o.i. of 20 PFU/cell with Ad5 or OAV wild-type and Hirt
DNA was prepared at 4 days postinfection (p.i.) (White et
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164 XU ET AL.al., 1984). As shown by analysis of XbaI-digested DNA,
and consistent with earlier observations (Gallimore,
1974), there was limited replication of Ad5 DNA during
this time. Similar analysis of NheI-digested DNA showed
that the OAV genome was not significantly amplified
(data not shown). Other cells that survived infection with
Ad5 or OAV wild-type at an m.o.i. of 10 were cultured. By
;40 days several morphologically distinct, flat epithe-
lioid colonies grew in the Ad5-infected cultures (Galli-
more, 1974) (Fig. 1B), but not in the OAV-infected cultures.
These colonies were picked and amplified and DNA was
extracted and tested for the presence of E1A and E1B
sequences by PCR analyses. Whereas control reactions
were negative, PCR products of 2.1 and 2.4 kb were
amplified for E1A and E1B sequences, respectively, as
FIG. 2. Transformation of baby rat kidney cells with Ad5 E1A/B or
OAV sequences. Cells were transfected with the indicated plasmids or
salmon sperm carrier DNA. The numbers in brackets correspond to the
microgram amounts of transfected plasmid DNA. Cells were stained
with crystal violet 21 days posttransfection, and one representative
plate for each transfection from one of several independent experi-
ments (Table 1) is shown.
T
Multilayered Focus Formation after Transfection of Prim
Line Plasmids transfected Expt. 1 Expt. 2
1 Carrier 0a 0
2 pAd5XhoIC (2.5)b 5 41
3 pAd5XhoIC (10) nd nd
4 pBamD (2.5) nd nd
5 pBamD (10) nd nd
6 pBamA (2.5) nd nd
7 pBamD (2.5)/pBamA (1) nd nd
8 pBamD (2.5)/pBamA (2.5) nd nd
Note. Expt., experiment. nd, not determined.
a Average number of transformed foci per 100-mm dish.
b Number in parentheses indicates the amount of transfected plasmid in mexpected (data not shown), consistent with the apparent
transformed phenotype of the colonies. In contrast, in
three similar experiments, no transformed foci were ob-
served among the cells that survived infection with OAV,
although these were maintained in parallel with the Ad5-
infected cultures for up to 80 days (Fig. 1B).
Similarly, when baby rat kidney cells were transfected
with pAd5XhoIC expressing E1A/B sequences, multilay-
ered, transformed foci readily appeared (Fig. 2 and Table
1, lines 2 and 3). However, cells transfected alone or in
combination with OAV plasmids pBamD and pBamA
(containing ORFs for all nonstructural proteins except
IVa2) did not produce such foci (Fig. 2 and Table 1, lines
–8). Collectively, these observations suggested that
AV sequences were not capable of transforming rat
ells, or at least, transformed them with a much lower
fficiency than Ad5 oncogenes.
ransformation of CSL503 cells
The ability of OAV sequences to transform CSL503
ells was examined next because such cells are permis-
ive for OAV replication and the viral promoters must
herefore function. It was also necessary to determine
hether Ad5 sequences could transform these cells and
hus serve as a positive control.
With Ad5 E1A/B sequences. CSL503 cells were trans-
ected with linear Ad5 sequences that included the E1A
nd E1B regions together (pE1-FR) or E1A sequences
lone (pE1AdelB). Cell monolayers were transfected with
.5, 5.5, 6.5, or 7.5 mg of DNA and split 10 days later. Foci
were first visible at ;day 14. Cells that were mock-
transfected did not produce foci. A total of 75, 165, 170,
and 182 foci of transformed cells developed, respectively,
by 28 days posttransfection. In contrast, cells transfected
with the same amounts of pE1AdelB produced 1, 0, 9,
and 1 clones, respectively, that were morphologically
distinct from surrounding cells but flat, rather than mul-
tilayered. These grew poorly when subcloned for expan-
sion. Several of the E1A/B-transformed clones (Fig. 3A)
by Rat Kidney Cells with Ad5- or OAV-Derived Plasmids
Expt. 3 Expt. 4 Expt. 6 Expt. 7 Expt. 8
0 0 0 0 0
37 60 7 22 11
42 155 35 nd nd
0 0 0 0 nd
0 0 0 nd nd
nd nd 0 nd 0
nd nd 0 nd 0
nd nd 0 nd 0ABLE 1
ary, Baicrograms.
p1-FR. E
A from
165LACK OF TRANSFORMATION BY OVINE ADENOVIRUSwere picked and expanded. Their morphology was dis-
tinct from the parental CSL503 cells (compare Fig. 3A,
lower panel with Fig. 4A). DNA extracted from these cells
was analyzed by PCR for the presence of Ad5 E1A/B
sequences. Products of ;2.1 and ;2.4 kb were expected
and observed for the E1A and E1B regions, respectively
(Fig. 3B). Thus, the production of these clones indicated
that there was no barrier to transformation of CSL503
cells.
With the left end of OAV. OAV pBamD encodes ORFs
LH1, LH2, and LH3 on the r-strand and the structural
rotein p32k on the l-strand of the genome (Khatri and
Both, 1998) (Fig. 5B). LH2 and LH3 may be distant ho-
mologues of the Ad5 E1B proteins, but LH1 is unique to
OAV (Khatri and Both, 1998; Vrati et al., 1996a). In an
attempt to produce cells that were similar in principle to
Ad5-transformed 293 cells (Graham et al., 1977), a variety
of transfection conditions were used to introduce pBamD
sequences into CSL503 cells together with the neomy-
cin-resistance gene cassette. However, very few G418-
resistant colonies grew well. From four experiments a
total of six colonies were transferred to 96-well plates but
of these, only two (clones 1 and 2) grew well enough to
allow stocks to be frozen down. The morphology of these
clones was similar to that of CSL503 cells (Fig. 4A).
These lines were thawed and reestablished in culture.
DNA and RNA were then extracted from each line and
analyzed by PCR. Primer pairs P1/P2 and P3/P4 (Fig. 5B)
produced the expected products of 2147 and 1262 bp,
FIG. 3. Analysis of CSL503 cell clones transfected with Ad5 E1/AB s
PCR analysis of DNA recovered from CSL503 cells transformed with pE
2–5) and c–d (lanes 6–9) (see Fig. 5A), respectively. pOAV610B and DNrespectively, from pBamD (Fig. 4B, lanes 4 and 8) and
clone 1 and clone 2 DNA (Fig. 4B, lanes 2 and 6 andlanes 3 and 7, respectively), but not from control CSL503
DNA (Fig. 4B, lanes 1 and 5). Analysis of RNA extracted
from OAV-infected CSL503 cells using RT-PCR and
primer pairs AK3/AK7 and AK3/AK10 (Fig. 4C) produced
the expected products of ;370 and ;435 bp, respec-
tively (Fig. 4C, lanes 3 and 7), that were not seen in
uninfected cells (Fig. 4C, lanes 2 and 6). These tran-
scripts appear to code for products of ORFs LH1 and
LH2. The same products were derived from clone 1 and
clone 2 RNA (Fig. 4C, lanes 4 and 5 and lanes 8 and 9).
The unspliced transcript that codes for LH3 (Fig. 5B) was
also detected in clone 2 RNA (data not shown). Thus,
these two clones contained integrated sequences that
represented the complete left end of OAV and expressed
transcripts for at least two of the three nonstructural
ORFs. However, they did not grow well or have a trans-
formed appearance (Fig. 4A).
With the other OAV sequences. Sequences in addition
to the left end of the OAV genome may be required for
transformation. Although it was not originally intended, a
de facto assessment of the transforming ability of OAV in
CSL503 cells was provided by the procedure used to
generate recombinant viruses. CSL503 cells were trans-
fected with linear OAV DNA using lipofectamine and
incubated for up to 4 weeks. The development of cpe
indicated virus rescue (Vrati et al., 1996b; Xu et al., 1997).
Although many OAV recombinants have now been res-
cued in our laboratory, over 100 dishes of cells (60 mm)
es. (A) Morphology of transformed foci before and after expansion. (B)
1A and E1B sequences were amplified using primer pairs a–b (lanes
nontransfected CSL503 cells were used as controls.equencthat were transfected never developed cpe and no mul-
tilayered, transformed foci were observed. Additional ex-
d clon
icated.
166 XU ET AL.periments to assess whether this was due to inefficient
transfection are described below.
In case the integration efficiency of the intact OAV
genome into the chromosomes was too low to induce
transformation, the viral genome was digested with
BamHI/KpnI to generate genome fragments of 4–8 kb.
KpnI released the intact, linear genome while BamHI cut
internally five times such that the nonstructural regions
(except for IVa2) remained intact (Vrati et al., 1996a,b).
KpnI/BamHI fragments were transfected into CSL503
cells (4 3 60-mm dishes; 3.4 mg DNA/5 3 105 cells).
Alternatively, in case potentially cooperative OAV se-
quences were separated by BamHI digestion, pOAV169
(;15 kb) (lacking ORFs for structural proteins; Fig. 5) was
digested with KpnI only and transfected under the same
gene dosage conditions. The cells were observed and
the medium was changed weekly. However, no multilay-
ered, transformed foci had appeared by 56 days although
occasional flat, morphologically distinct foci, reminiscent
of those seen with pE1AdelB, were seen.
With Ad5 E1A/B sequences in an OAV plasmid. To
distinguish between transformation-deficient OAV se-
quences and factors relating to gene dosage and/or
transfection efficiency, hybrid plasmids in which Ad5
E1A/B sequences were incorporated into the OAV ge-
FIG. 4. Analysis of CSL503 cell clones transfected with OAV left end
analysis of CSL503, clone 1, clone 2, and pBamD DNA using primer pa
transcripts from uninfected (U), OAV-infected (I) CSL503 and clone 1 an
6–9), as indicated. Lanes 1 and 10 contained markers of the sizes indnome were used to transfect CSL503 cells under condi-
tions used for OAV rescue. Ad5 E1A/B sequences wereinserted into the OAV genome between the pVIII and the
fiber genes (pOAV219) (Fig. 5) or into a site ;1 kb from
the right end of the genome (pOAV619). A plasmid
(pOAV610B) carrying unrelated sequences was used as
a control. These plasmids were partially digested with
KpnI to release at least one end of the linear genome
without cutting the internal site within the E1B gene.
DNAs were transfected with lipofectamine using stan-
dard conditions. Although this could have resulted in
rescue of recombinant OAV/Ad5 hybrid viruses, in two
experiments no cytopathic effect developed in any dish
of transfected cells. However, transformed foci with mor-
phology similar to that of pE1-FR-transformed cells de-
veloped in dishes transfected with pOAV219 and
pOAV619 (Table 2) but not with the control plasmid
pOAV610B. More foci were observed with pOAV619
where the Ad5 sequences were incorporated near one
end of the OAV genome. Cells transfected with
pOAV619B, in which only the Ad5 E1A sequences were
intact, produced a few morphologically distinct foci but
these were not multilayered.
Ovine lung transformed OLT219 and OLT619 colonies
were picked and amplified. Their morphology was clearly
distinct from CSL503 cells (Fig. 6A) and similar to that of
the cells transformed by E1A/B sequences (Fig. 3A). DNA
nces. (A) Morphology of CSL503, clone 1, and clone 2 cells. (B) PCR
P4 (Fig. 5B) (lanes 1–4) and P1/P2 (lanes 5–8). (C) RT-PCR analysis of
e 2 cells using primer pairs AK3/AK7 (lanes 2–5) and AK3/AK10 (lanesseque
irs P3/from the expanded cells was analyzed by PCR. E1A and
E1B sequences were detected in OLT619 DNA (Fig. 6B,
d
e
167LACK OF TRANSFORMATION BY OVINE ADENOVIRUSFIG. 5. Structure of plasmids and transcripts. (A) pE1-FR contains the Ad5 E1A/B regions in an inverted orientation. pE1AdelB was derived by HindIII
igestion and religation. pAd5E1A is a similar plasmid (not shown) derived from pXhoIC. The orientation of PCR primers a–d is indicated. Restriction
nzymes sites for BamHI (B), HindIII (H), KpnI (K), ClaI (C), and AgeI (A) are indicated. Solid bar indicates OAV genome sequences. Dashed lines in
pOAV169 indicate the deleted region. (B) Structure of the left end of the OAV genome. The open reading frames (striped bars), promoter regions
(stippled boxes), key transcripts (top), and relevant RT-PCR primers (AK3, AK7, and AK10) (Khatri and Both, 1998) are shown. OAV genome sequences
(black bar, scale in kilobases) were analyzed by PCR primers P1–P4.
168 XU ET AL.lanes 3 and 7) but not in the control pOAV610B or DNA
from CSL503 cells or (Fig. 6B, lanes 4 and 5). Identical
results were obtained on analysis of OLT219 cell DNA
(Fig. 6C, lanes 3 and 7). Clearly therefore, CSL503 cells
were transformed by Ad5 E1A/B sequences, whereas,
under the same conditions of gene dosage and trans-
fection, OAV sequences were never observed to achieve
this result.
Cotransfection of Ad5/E1A and OAV sequences
As OAV lacks an identifiable E1A function and appar-
ently cannot transform cells, we tested whether the com-
TABLE 2
Appearance of Transformed Foci after Transfection of CSL503
Cells with Hybrid OAV Plasmids
DNA 5a 6 7 8
Plasmid
Experiment 1
pOAV219 0b 0 2 3
pOAV619 0 1 5 6
pOAV610B 0 0 0 0
Experiment 2
pOAV219 2 3
pOAV619 0 2 4 4
pOAV619B 0 0 1c 1c
a mg DNA used for transfection.
b Total number of transformed foci in two 60-mm dishes of cells after
23 days.
c Cells morphologically different from E1A/B transformed foci.
FIG. 6. Analysis of OLT619 and OLT219 clones. (A) Morphology of clo
c–d (Fig. 5) representing E1A and E1B sequences, respectively, were used
pOAV610B and DNA from nontransfected CSL503 cells were used as controlbinations of Ad5 E1A and OAV sequences could cooper-
ate to induce the appearance of transformed foci.
CSL503 cells were transfected with pE1-FR or pE1AdelB
plus various OAV plasmids and the appearance of mul-
tilayered foci was monitored. pBamC was used to adjust
DNA levels between experiments. However, foci were
observed only when pE1-FR, the Ad5 E1A/B control plas-
mid, was used. Combinations of Ad5 E1A sequences
with OAV pBamD (left end) or pOAV169 (all the nonstruc-
tural coding sequences) failed to induce multilayered
colony formation (Fig. 7). When baby rat kidney cells
were transfected with combinations of Ad5 E1A and the
left end clone (pBamD) of OAV a small increase in the
number of transformed colonies was observed com-
pared to transfections with E1A alone (Fig. 8). However,
this increase may not be significant and these colonies
did not exhibit the multilayered morphology that was
typical of foci transformed by E1A/B sequences.
DISCUSSION
A large body of work conducted over many years has
investigated the oncogenic properties of adenoviruses. It
is now clear that the mastadenoviruses, which include
all known human Ads, contain several groups of viruses
whose tumor-inducing properties differ, although they all
share an ability to transform susceptible cells during
nonlytic infection (reviewed in Flint, 1980; Horwitz, 1990).
In addition, mastadenoviruses of animal origin can also
transform certain cell types or cause tumors (Darbyshire,
1966; Mittal et al., 1995; Panigrahy et al., 1976; Tsukiyama
nsformed with pOAV219 and pOAV619 plasmids. Primers pairs a–b andnes tra
for amplification of OLT619 (B) and OLT219 (C) DNAs, respectively.
s. Lanes M contain markers of the sizes indicated.
p
s
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169LACK OF TRANSFORMATION BY OVINE ADENOVIRUSet al., 1988). Similarly, CELO virus, a member of the
aviadenoviruses, can induce tumors in rodents (Sarma et
al., 1965) and transform heterologous cells (Anderson et
al., 1969a,b; Kinjo et al., 1969; McAllister et al., 1969;
Trentin et al., 1962). There is only one unconfirmed report
of tumor induction in hamsters by bovine Ad8 (Rondhuis,
1973), a member of the proposed atadenovirus group
(Benko and Harrach, 1998). However, in an earlier study
using a related Ad8 isolate, tumor formation in hamsters
was not observed (Mohanty, 1971). The difference may
be due to the smaller amount of virus that was used for
inoculation in the first study (Mohanty, 1971).
OAV is the prototype member of the proposed third
genus of adenoviruses (Benko and Harrach, 1998;
Harrach and Benko, 1999; Harrach et al., 1997) and is
being developed as a potential gene delivery vector.
Current vectors carry an expression cassette at a non-
essential site in the genome while retaining the full
complement of viral genes (Khatri et al., 1997; Vrati et al.,
1996b; Xu et al., 1997). Thus, the issue of whether this
virus has transforming ability is of interest from a funda-
mental viewpoint and from a safety perspective. Many
ORFs and transcripts of the OAV genome have been
defined (Khatri and Both, 1998; Vrati et al., 1996a) but the
proteins have not been identified. As many of the ORFs
encoding nonstructural proteins have no obvious homol-
ogy with other Ad sequences, their functions are un-
known. OAV may have homologues of the Mastadenovi-
rus E1B and E4 coding sequences but apparently it has
no E1A gene. However, this is also true for CELO
(Chiocca et al., 1996), a virus that has both transforming
and tumorigenic activities (Anderson et al., 1969a,b; Dar-
byshire, 1966; Kinjo et al., 1969; McAllister et al., 1969;
Sarma et al., 1965; Trentin et al., 1962). The situation for
bovine Ad8 is unknown because its sequence has not
been determined.
FIG. 7. Transformation of CSL503 cells with Ad5 E1A plus OAV
sequences. Cells were transfected with (1) pE1-FR (5 mg) 1 pBamC (5
mg), (2) pE1AdelB (5 mg) 1 pBamC (5 mg), (3) pE1AdelB (6 mg) 1
BamD (6 mg), or (4) pE1AdelB (5 mg) 1 pOAV169 (5 mg). Cells were
plit 1:2 at day 13 and stained with crystal violet at day 35 posttrans-
ection.To ascertain whether OAV has oncogenic properties,
we investigated its ability to transform cells that havebeen used in similar studies with other viruses. Primary
rat embryo cells were infected in parallel with OAV or
Ad5, a virus that is known to carry transforming se-
quences (reviewed in Flint, 1980; Horwitz, 1990). Both
Ad5 and OAV apparently infected primary rat embryo
cells but only after Ad5 infection were clones of distinct
morphology observed to grow out from surviving cells.
PCR analysis showed that these carried Ad5 E1A/B se-
quences, as expected. Similarly, Ad5 E1A/B sequences
transformed baby rat kidney cells following transfection
while sequences from the left end of the OAV genome
did not. The trivial explanation, that OAV promoters did
not function in rat cells, seems unlikely as they do func-
tion in other animal and human cell types (Khatri et al.,
1997).
To rule out the trivial explanation, OAV sequences
were transfected into the sheep fetal lung cell line,
CSL503 (Pye, 1989), in which OAV is known to replicate
(Boyle et al., 1994). This situation mimicked the transfec-
tion of human embryonic kidney cells with sheared Ad5,
a strategy that produced the transformed 293 cell line
(Graham et al., 1977). Several approaches to transform
CSL503 cells with OAV sequences were tried. Cell
clones that were stably transfected with sequences from
the left end of the genome were selected using neomy-
cin, expanded, and frozen down. Upon revival two clones
that carried the appropriate OAV genome sequences
were identified and shown by RT-PCR to produce tran-
scripts for at least two of the ORFs. Clone 2 also ex-
pressed the unspliced LH3 transcript. However, despite
this stable expression, both clones grew poorly and were
morphologically similar to the parental CSL503 cell line.
In case transformation required cooperation between
sequences that were located in distant parts of the
genome, CSL503 cells were transfected with a mixture of
restriction fragments representing the entire genome or
a plasmid in which the nonstructural genes were intact.
FIG. 8. Transformation of baby rat kidney cells with Ad5 E1A plus
OAV sequences. Cells were transfected with the indicated plasmids (5
mg) or salmon sperm carrier DNA and stained with crystal violet 21
days posttransfection. Two representative plates for each transfection
from one of two independent experiments are shown.
170 XU ET AL.In addition, transfection of the entire OAV genome into
CSL503 cells during many attempts at virus rescue pro-
vided a de facto assessment of the transforming ability of
OAV sequences. With none of the above approaches did
multilayered transformed foci appear in CSL503 cell
monolayers. In contrast, transfection of CSL503 cells
with Ad5 E1A/B sequences resulted in the appearance of
many transformed foci that, upon expansion, were
shown to carry Ad5 E1A/B sequences. Thus, there was
no impediment to transformation of CSL503 cells. Impor-
tantly, when Ad5 E1A/B sequences were incorporated
into OAV plasmids and introduced into CSL503 cells
under transfection and gene dosage conditions identical
to those used for virus rescue, transformed foci again
appeared. The conclusion therefore is that OAV lacks
sequences that are capable of transformation in the cell
types that were tested. OAV sequences also failed to
suppress transformation by Ad5 E1A/B sequences.
As OAV lacks identifiable E1A sequences, attempts
were also made to provide this function using plasmids
carrying the Ad5 E1A region. However, combinations of
Ad5 E1A with the left end or the left plus right ends of the
OAV genome (including all of the nonstructural ORFs)
again failed to induce multilayered focus formation. Baby
rat kidney cells transformed with Ad5 E1A plus OAV
pBamD sequences did not display the multilayered mor-
phology that is typical for E1A/E1B transformed foci.
These results suggest that at best, sequences from the
left end of OAV may cooperate with Ad5 E1A to enhance
the efficiency with which morphologically altered cells
arise without creating a fully transformed phenotype.
The apparent inability of OAV to transform cells in the
way that Ad5 E1A/B sequences do is consistent with the
absence of an E1A homologue or a substituting function
in the OAV genome. The E1A protein binds the pRb family
of proteins (Whyte et al., 1988), thereby releasing E2F
transcription factors. Promoters that control cell cycle
progression into S phase as well as the Ad E1A and E2
promoters are activated (Kovesdi et al., 1987; Nevins,
1992). Although CELO virus lacks E1A it also codes for
proteins that bind pRb, thus modulating the E2F protein
family (Lehrmann and Cotten, 1999). It is noteworthy
therefore that the OAV E2 promoter region, whose se-
quence and approximate location have been determined
(Khatri and Both, 1998; Vrati et al., 1996a), lacks an E2F
binding site of the type TTTc/gGCGCc/g (Zheng et al.,
1999). Nevertheless, the promoter is active in numerous
cell lines although OAV replication is abortive (Khatri et
al., 1997). Thus, OAV interacts with the cellular machinery
in a way that differs fundamentally from the mastadeno-
viruses and aviadenoviruses. Although many different
cell lines are infected by OAV (Khatri et al., 1997), the only
known cell line in which OAV replicates to high titer is the
fetal lung cell line CSL503 (Pye, 1989). Similarly, bovine
Ad members of the proposed new genus show a strong
preference for replication in primary cultures (Mohanty,1971). Viruses in this group therefore seem to have a
narrower host range for replication compared with other
Ads, perhaps because they cannot induce the cell to
enter S phase (bovine Ad8 is a possible exception). This
warrants further investigation.
MATERIALS AND METHODS
Cells and viruses
Embryos were removed from a Copenhagen rat at ;10
days of gestation (Loo and Cotman, 1994), the heads
were removed, and primary cells were prepared and
maintained in DMEM plus 10% FCS. Baby rat kidney cells
were prepared as previously described (Nevels et al.,
1997) and maintained in the same medium. The sheep
fetal lung cell line CSL503 (Pye, 1989) was grown in
EMEM plus 10% FCS. Human adenovirus type 5 was
obtained from the ATCC. The source of the OAV isolate
OAV287 has been previously described (Boyle et al.,
1994; Peet et al., 1983). A recombinant, OAV217A, that
expressed the GFP protein was also constructed. A hu-
manized GFP gene (provided by Dr. Shinichi Aota, Bio-
molecular Engineering Research Institute, Japan) was
blunt-cloned into the XhoI/SmaI sites of plasmid pCI
(Promega Corp., Madison, WI). The cassette was sub-
cloned as a BamHI/BglII blunt-ended fragment into the
XbaI site of pGem11zf (Promega). The intron in the cas-
sette was removed by fusing the two AflII sites. The
cassette was then subcloned as an ApaI/NotI fragment
into site I of plasmid OAV200 and the virus was rescued
as described previously (Vrati et al., 1996b). Ad5 and OAV
were titrated by plaque assays on 293 or CSL503 cells,
respectively (Graham and Prevec, 1991).
Plasmids
Plasmid pAd5XhoIC contains the left end of the Ad5
genome, including the E1A/B regions (Logan et al., 1984).
Plasmid pAd5E1A was derived from pAd5XhoIC by re-
striction digestion with BstEII and religation, eliminating
most of the E1B coding sequences. Plasmid pE1-FR
(provided by Dr. R. I. Garver, Gene Therapy Program,
University Alabama at Birmingham) also contains the
Ad5 E1A and E1B sequences but in an inverted juxta-
posed configuration (Fig. 5A). This plasmid was previ-
ously characterized and used to complement deleted
E1A/B functions in replication-deficient Ad5 viruses
(Dion et al., 1996). Digestion with HindIII, followed by
ligation, eliminated the E1B promoter and much of the
E1B coding sequence, producing pE1AdelB. Plasmids
pBamD and pBamA (Boyle et al., 1994) carry the left-hand
;4.25-kb and right hand ;8.7-kb BamHI fragments of
the OAV genome, respectively, in the BamHI/HincII sites
of Bluescribe M131 (Stratagene, San Diego, CA). KpnI
sites were subsequently added at the ends of the ge-
nome in pBamA and pBamD (Vrati et al., 1996b). pOAV169
f
b
A
q
b
(
f
s
T
i
p
s
p
s
(
T
p
d
(
a
C
p
g
g
d
(
w
B
m
p
1
u
s
(
a
1
171LACK OF TRANSFORMATION BY OVINE ADENOVIRUSwas prepared from pOAV100, a plasmid containing the
entire OAV genome in a modified Bluescribe plasmid
(Vrati et al., 1996b), by digestion with ClaI and AgeI,
followed by blunt-end repair and ligation (Sambrook et
al., 1989). These enzymes cut within ORFs for DNA poly-
merase and fiber, respectively, leaving nonstructural se-
quences intact while deleting all structural proteins (ex-
cept for p32k). To construct pOAV219, Ad5 E1A/B se-
quences were excised from pE1-FR as an EcoRI/BamHI
ragment, blunt-end repaired, and subcloned into the
lunted XbaI site of pGem11zf (Promega). The flanking
paI/NotI sites were used to subclone the Ad5 se-
uences into the ApaI/NotI sites of pOAV200, located
etween the pVIII and the fiber genes (Vrati et al., 1996b)
Fig. 5A). Similarly, the SalI site of pOAV287Cm (;1 kb
rom the right end of the genome) was modified with a
ynthetic oligonucleotide containing SalI/ApaI/NotI sites.
he ApaI/NotI-flanked Ad5 sequences were also cloned
nto that plasmid to construct pOAV619 (Fig. 5A).
OAV619B contains only the pE1AdelB sequences in the
ame insertion site (not shown). pOAV610B is a control
lasmid in which the HCMV/alkaline phosphatase cas-
ette was inserted at the same site (Khatri et al., 1997)
Fig. 5A).
ransfection of cells and transformation assays
Primary baby rat kidney cells were transfected with
lasmids and assayed for focus formation as previously
escribed (Nevels et al., 1997, 1999b). OAV plasmids
;33 kb) were cut with KpnI to release the linear genome
nd DNA (5–8 mg per 5 3 105 cells) was transfected into
SL503 cells using lipofectamine (Gibco BRL) (12–16 ml)
(Vrati et al., 1996b). Plasmids pE1-FR and pE1AdelB were
made linear by ScaI digestion prior to transfection under
similar conditions. To produce cell lines stably trans-
fected with the OAV left end, pBamD was made linear
with BamHI and transfected into CSL503 cells using
electroporation or CaPO4 precipitation together with a
lasmid (ratio 10:1) carrying the neomycin-resistance
ene expressed from the thymidine kinase or phospho-
lycerate kinase promoter. Cells were maintained in me-
ium containing 200–300 mg/ml of G418. Neomycin-re-
sistant clones that appeared were lifted into 96-well
plates and expanded for further analysis.
PCR analysis
DNA was extracted from transfected cells by SDS/
pronase treatment (White et al., 1984). Primers for PCR
amplification of DNA from the left end of OAV (Fig. 5B)
corresponding to bases 72–93 (P1, 1sense), 2198–2219
P2, 2sense), 2137–2159 (P3, 1), and 3379–3400 (P4, 2)
ere designed from the known sequence of OAV (Gen-
ank Accession No. U40839). Transcripts from OAV pro-
oters LH1 and LH2 were amplified by RT-PCR using
rimer pairs AK3/AK7 and AK3/AK10 (Khatri and Both,998) (primer details available on request). Primer pairs
sed to amplify Ad5 E1A sequences in pE1-FR corre-
ponded to bases 30–53 (primer “a”) and 3644–3666
primer “b”) of the Ad5 genome. Ad5 E1B sequences were
mplified using primers corresponding to bases 1677–
691 (primer “d”) and 4067–4090 (primer “c”) (Fig. 5A).
ACKNOWLEDGMENTS
We thank P. Molloy for critically reviewing the manuscript and M.
Benko for a historical perspective on the literature. D. Curiel is sup-
ported by the following grants: National Institutes of Health-R01
CA74242, National Institutes of Health-R01 HL50255, National Institutes
of Health-R01 CA83821, National Cancer Institutes-N01 CO97110,
United States Department of Defense-PC970193, United States Depart-
ment of Defense-PC991018.
REFERENCES
Anderson, J., Yates, V., Jasty, V., and Mancini, L. (1969a). In vitro trans-
formation by an avian adenovirus (CELO). I. Hamster-embryo fibro-
blastic cultures. J. Natl. Cancer Inst. 42, 1–7.
Anderson, J., Yates, V., Jasty, V., and Mancini, L. (1969b). In vitro trans-
formation by an avian adenovirus (CELO). II. Hamster kidney cell
cultures. J. Natl. Cancer Inst. 43, 65–70.
Benko, M., and Harrach, B. (1998). A proposal for a new (third) genus
within the family Adenoviridae. Arch. Virol. 143, 829–837.
Boyle, D. B., Pye, A. D., Kockerhans, R., Adair, B. M., Vrati, S., and Both,
G. W. (1994). Characterisation of Australian ovine adenovirus iso-
lates. Vet. Microbiol. 41, 281–291.
Chiocca, S., Baker, A., and Cotten, M. (1997). Identification of a novel
antiapoptotic protein, GAM-1, encoded by the CELO adenovirus.
J. Virol. 71, 3168–3177.
Chiocca, S., Kurzbauer, R., Schaffner, G., Baker, A., Mautner, V., and
Cotten, M. (1996). The complete DNA sequence and genomic orga-
nization of the avian adenovirus CELO. J. Virol. 70, 2939–2949.
Dan, A., Ruzsics, Z., Russell, W. C., Benko, M., and Harrach, B. (1998).
Analysis of the hexon gene sequence of bovine adenovirus type 4
provides further support for a new adenovirus genus (Atadenovirus).
J. Gen. Virol. 79, 1453–1460.
Darbyshire, J. (1966). Oncogenicity of bovine adenovirus type 3 in
hamsters. Nature 211, 102.
Dion, L. D., Goldsmith, K. T., and Garver, R. I. J. (1996). Quantitative and
in vivo activity of adenoviral-producing cells made by cotransduction
of a replication-defective adenovirus and a replication-enabling plas-
mid. Cancer Gene Ther. 3, 230–237.
Flint, S. (1980). Cell transformation induced by adenoviruses. In “DNA
Tumor Viruses” (J. Tooze, Ed.), 2nd ed., part 2, pp. 574–576. Cold
Spring Harbor Press, Cold Spring Harbor, NY.
Gallimore, P. (1974). Interactions of adenovirus type 2 with rat embryo
cells. Permissiveness, transformation and in vitro characteristics of
adenovirus transformed rat embryo cells. J. Gen. Virol. 25, 263–273.
Graham, F. L., and Prevec, L. (1991). Manipulation of adenovirus vec-
tors. In “Methods in Molecular Biology” (E. J. Murray and J. M. Walker,
Eds.), Vol. 7, pp. 1–19. Humana Press, Clifton, NJ.
Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977). Charac-
teristics of a human cell line transformed by DNA from human
adenovirus type 5. J. Gen. Virol. 36, 59–72.
Harrach, B., and Benko, M. (1999). Phylogenetic analysis of adenovirus
sequences—Proof of the necessity of establishing a third genus in
the Adenoviridae family. In “Adenovirus Methods And Protocols”
(W. S. M. Wold, Ed.), Vol. 21, pp. 309–339. Humana Press, Totowa, NJ.
Harrach, B., Meehan, B. M., Benko, M., Adair, B. M., and Todd, D. (1997).
Close phylogenetic relationship between egg drop syndrome virus,
bovine adenovirus serotype 7, and ovine adenovirus strain 287. Vi-
rology 229, 302–306.
172 XU ET AL.Hess, M., Blocker, H., and Brandt, P. (1997). The complete nucleotide
sequence of the egg drop syndrome virus: An intermediate between
mastadenoviruses and aviadenoviruses. Virology 238, 145–156.
Horwitz, M. S. (1990). Adenoviridae and their replication. In “Virology”
(B. N. Fields and D. M. Knipe, Eds.), 2nd ed., pp. 1679–1721. Raven
Press, New York.
Javier, R., Raska, K., and Shenk, T. (1992). Requirement for the adeno-
virus type 9 E4 region in production of mammary tumors. Science
257, 1267–1271.
Khatri, A., and Both, G. W. (1998). Identification of transcripts and
promoter regions of ovine adenovirus OAV287. Virology 245, 128–141.
Khatri, A., Xu, Z. Z., and Both, G. W. (1997). Gene expression by atypical
recombinant ovine adenovirus vectors during abortive infection of
human and animal cells in vitro. Virology 239, 226–237.
Kinjo, T., Nishi, T., and Yanagawa, R. (1969). In vitro transformation of
hamster cells by infectious canine hepatitis virus. Jpn. J. Vet. Res. 17,
128–135.
Kovesdi, I., Reichel, R., and Nevins, J. R. (1987). Role of an adenovirus
E2 promoter binding factor in E1A-mediated coordinate gene control.
Proc. Natl. Acad. Sci. USA 84(8), 2180–2184.
Lehrmann, H., and Cotten, M. (1999). Characterization of CELO virus
proteins that modulate the pRb/E2F pathway. J. Virol. 73, 6517–6525.
Logan, J., Pilder, S., and Shenk, T. (1984). Functional analysis of ade-
novirus type 5 early region 1B. Cancer Cells 2, 527–532.
Loo, D., and Cotman, C. (1994). Primary and extended culture of em-
bryonic mouse cells: Establishment of a novel cell culture model of
apoptosis and neuronal differentiation. In “Cell Biology: A Laboratory
Handbook” (J. Celis, Ed.), Vol. 1, pp. 45–53. Academic Press, London.
McAllister, R., Nicolson, M., Lewis, A. M. J., Macpherson, I., and Hueb-
ner, R. (1969). Transformation of rat embryo cells by adenovirus type
1. J. Gen. Virol. 4, 29–36.
Mittal, S. K., Prevec, L., Graham, F. L., and Babiuk, L. A. (1995). Devel-
opment of a bovine adenovirus type 3-based expression vector.
J. Gen. Virol. 76, 93–102.
Mohanty, S. B. (1971). Comparative study of bovine adenoviruses. Am. J.
Vet. Res. 32, 1899–1905.
Moore, M., Horikoshi, N., and Shenk, T. (1996). Oncogenic potential of the
adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. USA 93, 11295–11301.
Nevels, M., Rubenwolf, S., Spruss, T., Wolf, H., and Dobner, T. (1997).
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus
formation by interfering with p53 tumor suppressor function. Proc.
Natl. Acad. Sci. USA 94, 1206–1211.
Nevels, M., Spruss, T., Wolf, H., and Dobner, T. (1999a). The adenovirus
E4orf6 protein contributes to malignant transformation by antagoniz-
ing E1A-induced accumulation of the tumor suppressor protein p53.
Oncogene 18, 9–17.
Nevels, M., Tauber, B., Kremmer, E., Spruss, T., Wolf, H., and Dobner, T.
(1999b). Transforming potential of the adenovirus type 5 E4orf3 pro-
tein. J. Virol. 73, 1591–1600.
Nevins, J. R. (1992). E2F: A link between the Rb tumor suppressor
protein and viral oncoproteins. Science 258, 424–429.
Panigrahy, B., McCormick, K. J., and Trentin, J. J. (1976). In vitro trans-
formation of rodent cells by simian adenovirus 7 and bovine adeno-
virus type 3 (strain WBR-1). Am. J. Vet. Res. 37, 1503–1504.Peet, R. L., Coackley, W., Purcell, D. A., Robartson, C. W., and Micke,
B. M. (1983). Adenovirus inclusions in sheep liver. Aust. Vet. J. 60,
307–308.
Pye, D. (1989). Cell lines for growth of sheep viruses. Aust. Vet. J. 66,
231–232.
Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S., and
White, E. (1992). The adenovirus E1A proteins induce apoptosis,
which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl.
Acad. Sci. USA 89, 7742–7746.
Rondhuis, P. R. (1973). Induction of tumors in hamsters with a bovine
adenovirus strain (serotype 8). Arch. Gesamte Virusforsch 41, 147–
149.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). “Molecular Cloning:
A Laboratory Manual,” 2nd ed. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY.
Sarma, P., Huebner, R., and Lane, W. (1965). Induction of tumors in
hamsters with an avian adenovirus (CELO). Science 149, 1108.
Shenk, T. (1996). Adenoviridae: The viruses and their replication. In
“Fields Virology” (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.),
3rd ed., Vol. 2, pp. 2111–2148. Lippincott–Raven, Philadelphia.
Thomas, D. L., Shin, S., Jiang, B. H., Vogel, H., Ross, M. A., Kaplitt, M.,
Shenk, T. E., and Javier, R. T. (1999). Early region 1 transforming
functions are dispensable for mammary tumorigenesis by human
adenovirus type 9. J. Virol. 73, 3071–3079.
Trentin, J. J., Yabe, Y., and Taylor, G. (1962). The quest for human cancer
viruses. Science 137, 835.
Tsukiyama, T., Shibata, R., Katayama, Y., and Shinagawa, M. (1988).
Transforming genes of canine adenovirus type 2. J. Gen. Virol. 69,
2471–2482.
Vrati, S., Brookes, D. E., Strike, P., Khatri, A., Boyle, D. B., and Both, G. W.
(1996a). Unique genome arrangement of an ovine adenovirus: Iden-
tification of new proteins and proteinase cleavage sites. Virology
220, 186–199.
Vrati, S., MacAvoy, E. S., Xu, Z. Z., Smole, C., Boyle, D. B., and Both, G. W.
(1996b). Construction and transfection of ovine adenovirus genomic
clones to rescue modified viruses. Virology 220, 200–203.
White, E. (1998). Regulation of apoptosis by adenovirus E1A and E1B
oncogenes. Semin. Virol. 8, 505–513.
White, E., Grodzicker, T., and Stillman, B. (1984). Mutations in the gene
encoding the adenovirus early region 1B 19,000-molecular-weight
tumor antigen cause the degradation of chromosomal DNA. J. Virol.
52, 410–419.
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M.,
Weinberg, R. A., and Harlow, E. (1988). Association between an
oncogene and an anti-oncogene: The adenovirus E1A proteins bind
to the retinoblastoma gene product. Nature 334, 124–129.
Xu, Z. Z., Hyatt, A., Boyle, D. B., and Both, G. W. (1997). Construction of
ovine adenovirus recombinants by gene insertion or deletion of
related terminal region sequences. Virology 230, 62–71.
Zheng, N., Fraenkel, E., Pabo, C. O., and Pavletich, N. P. (1999). Struc-
tural basis of DNA recognition by the heterodimeric cell cycle tran-
scription factor E2F-DP. Genes Dev. 13, 666–674.
